Ann Mosher

Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis

William J. Burman, Stefan Goldberg, John L. Johnson et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 284 citations

Discriminating between latent and active tuberculosis with multiple biomarker responses

Marc A. Frahm, Neela D. Goswami, Kouros Owzar et al. · Tuberculosis · 2011 · 147 citations · Full text

Biomarker (Medicine), Prognostic Biomarkers, Pulmonary Tuberculosis +10

A Prospective, Randomized, Double-Blind Study of the Tolerability of Rifapentine 600, 900, and 1,200 mg Plus Isoniazid in the Continuation Phase of Tuberculosis Treatment

Naomi Bock, Timothy R. Sterling, Carol Hamilton et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 71 citations

Tuberculosis Treatment, Adverse Events, Pulmonary Tuberculosis +13

Geographic Information System-based Screening for TB, HIV, and Syphilis (GIS-THIS): A Cross-Sectional Study

Neela D. Goswami, Emily J. Hecker, Carter Vickery et al. · PLoS ONE · 2012 · 54 citations · Full text

Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22)

Donna Sepulveda Conwell, Ann Mosher, Awal Khan et al. · Contemporary Clinical Trials · 2006 · 13 citations

Pulmonary Tuberculosis, Tuberculosis Prevention, Clinical Epidemiology +6